Ismigen to prevent respiratory infections in children
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a medicine called Ismigen can help children who get frequent respiratory infections (like colds, bronchitis, or throat infections) stay healthier. The medicine is made from bacterial components designed to strengthen the immune system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be between 3 and 12 years old
- No active respiratory infection in the 15 days before starting the study
- Child has a pattern of getting respiratory infections frequently
- Able to take study tablets as directed and follow study visits
- No serious immune system disorders, cystic fibrosis, or severe chronic lung disease (asthma and allergies are okay)
- Girls of childbearing age must use contraception during the study and have a negative pregnancy test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how South African children's immune systems respond to acute respiratory infections. It may help find better ways to treat or prevent these infections.
This study tests a medication called OM 85 that may help prevent respiratory infections (like pneumonia) in older adults living in nursing homes. If you are 75 or older and have had infections recently, this trial could be a way to stay healthier.
This study tests a new way to quickly identify respiratory infections in children using a nose swab. It aims to help doctors choose the right treatment faster and avoid unnecessary antibiotics.
This study tracks patients with breathing problems to see which germs are making them sick. Doctors will use tests and medical records to watch for different pathogens.
This study looks at how gut bacteria, immune markers, and trace elements in the blood relate to respiratory infections in children. It aims to better understand why some children get sick more often, which could lead to better treatments.
This study tests whether a bacterial “lysate” medicine, given to preterm babies, can reduce respiratory (lung) infections and wheezing. It may help protect babies’ airways during the vulnerable first months after birth.
Hear when a new Respiratory Tract Infections (RTI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.